Surgical management of pancreatic cancer.

Steven A. Ahrendt, Henry A. Pitt

Research output: Contribution to journalReview articlepeer-review


Pancreatic cancer is the fifth leading cause of cancer death in the United States, with an overall survival rate of 3%. Unfortunately, only a minority of patients present with localized disease amenable to surgical resection. Over the past 20 years, improvements in operative and perioperative management have led to a decrease in operative mortality, shorter hospital stay, and overall 5-year survival of approximately 20% in patients undergoing pancreaticoduodenectomy. Despite advances in nonoperative palliation, surgery continues to play an important role in the management of patients with locally advanced, unresectable pancreatic cancer.

Original languageEnglish (US)
Pages (from-to)725-734; discussion 734, 736-738, 740, 743
JournalOncology (Williston Park, N.Y.)
Issue number6
StatePublished - Jun 2002

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Surgical management of pancreatic cancer.'. Together they form a unique fingerprint.

Cite this